Teva Pharmaceutical Industries reported $1.15B in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Aspen Pharmacare ZAR 444.23M 1.21B Dec/2024
Cipla INR 1.62B 100K Mar/2025
Dr.Reddys Laboratories INR 834M 0 Mar/2025
Guangzhou Baiy CNY 1.63B 1 Jun/2025
Jiangsu Hengrui CNY 6.64B 258.2M Jun/2025
Kalbe Farma IDR 45.39B 423.36B Jun/2025
Richter Gedeon HUF 18.64B 0 Dec/2024
Sh Fosun Pharma CNY 2.67B 897.14K Jun/2025
Sun Pharmaceuticals INR 2.4B 0 Mar/2025
Teva Pharmaceutical Industries USD 1.15B 1.09B Jun/2025